Daniel Pella
Researcher Next ID · RN-015875
Researcher · Medicine
University of Pavol Jozef Šafárik
, Slovakia
- Works count
- 227
- Citation count
- 35,421
- H-index
- 45
- i10-index
- 106
Research interests
Publications
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis · 2019 · 10.1016/j.atherosclerosis.2019.08.014
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
New England Journal of Medicine · 2017 · 10.1056/nejmoa1707914
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
The Lancet · 2017 · 10.1016/s0140-6736(17)32247-x
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
The Lancet · 2017 · 10.1016/s0140-6736(17)32814-3
Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial
The Lancet · 2002 · 10.1016/s0140-6736(02)11472-3
Current projects
No projects listed.